Stacy Ehrlich, a graduate of Emory University and Harvard Law School, has been practicing food and drug law since 1995. Ms. Ehrlich represents clients regulated by the Food and Drug Administration, Federal Trade Commission, Consumer Product
Safety Commission, Drug Enforcement Administration, Department of Agriculture, and other health and safety regulatory agencies at both the federal and state level.
While her practice includes all aspects of consumer product regulation, Ms. Ehrlich has particular expertise with the marketing and labeling of dietary supplements and conventional foods, pharmaceutical and medical device marketing and promotion, Lanham Act false advertising and administrative litigation, and privacy issues affecting pharmaceutical and medical device companies. Ms. Ehrlich advises clients in a wide range of matters, such as issues related to orphan drug and pediatric exclusivity, Hatch-Waxman, pharmacy compounding, health care fraud and abuse, and the Prescription Drug Marketing Act (PDMA).
Ms. Ehrlich has made presentations and authored articles relating to various issues of food and drug law, including pharmaceutical promotion, OTC drug labeling, OTC drug and dietary supplement combination products, the PDMA, expedited approval and exclusivity issues, marketing beverage-type products as dietary supplements, and corporate compliance. Ms. Ehrlich additionally co-authored a chapter in the Food and Drug Law Institute publication, How to Work with the FDA.
Food and drug law, including issues relating to foods and beverages, dietary supplements, pharmaceuticals, biological products, medical devices, cosmetics and other consumer products.